David B. Colleran
General Counsel
Anika Therapeutics, Inc. (ANIK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About David B. Colleran
David B. Colleran is recorded as General Counsel at Anika Therapeutics, Inc. (ANIK). The proxy statement of Anika Therapeutics, Inc. reports total compensation of $1,668,587 for David B. Colleran in fiscal 2024, including a base salary of $481,996. Disclosed compensation is on record for 7 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Anika Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Cheryl Blanchard CEO, Board Member
- Stephen (Steve) Griffin CEO, Board Member
- Stephen D. Griffin CEO, CFO, Board Member
- Steve Griffin CEO, Board Member
- Cheryl R. Blanchard Chairman, Board Member
- Jeffery S. Thompson Chairman
- John B. Henneman, III Chairman, Board Member
- Michael Levitz CFO
- Stephen Griffin CFO
- Anne Nunes COO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $481,996 | $1,668,587 |
| 2023 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $469,900 | $1,550,514 |
| 2022 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $449,700 | $1,651,635 |
| 2021 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $432,400 | $1,400,513 |
| 2020 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | $344,077 | $1,705,616 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | — | — |
| 2018 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.